Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Pharmacy2U dispensing hub contract appealed by NHS

The NHS contract awarded to Pharmacy2U’s dispensing hub in Leicester has been appealed by NHS Resolution.

The online pharmacy business was previously granted an NHS contract for its second dispensing hub by NHS England, but this decision has now been appealed by NHS Resolution.

NHS Resolution confirmed to C+D yesterday (January 29) that the contract had been appealed, and said it has no further comment to make at present. The organisation added that its “full decision” will be published next week.

The Leicester facility is the second Pharmacy2U dispensing hub, and the company has said it will enable it to “dispense over six million medicines a month”.

“We had our license for the new facility approved previously by NHS England so we are disappointed that it has been held up on appeal,” it told C+D on Monday (January 27).

The company said it will work with the NHS to “ensure all feedback is answered and changes are made” to its application.

In a post on Linkedin last week, pharmacist and lawyer Conor Daly claimed the reason for the appeal was that the committee “could not be satisfied that the proposed procedures would secure a safe and effective service”. However this remains unconfirmed by NHS Resolution and Pharmacy2U.

In its 2018-19 financial report, Pharmacy2U said it would use part of a £40m equity investment secured in March 2018 to fund the development of this second automated dispensing hub.

What do you make of NHS Resolution's appeal?

Related Content


Pharmacy Manager / Pharmacist

Apply Now
Latest News & Analysis
See All



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts